abstract |
The invention relates to the application of dimethyl itaconate in the preparation of medicines for treating and/or preventing obesity-induced intestinal microecological disorders. It has been experimentally verified that dimethyl itaconic acid can correct intestinal microbial dysbiosis, down-regulate intestinal inflammation, and maintain the integrity of the intestinal barrier in obese mice. |